Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.

Clinical trial NCT00418275 · COMPLETED

Trial details

NCT number: NCT00418275
Sponsor: Global Biotech
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cerebrovascular Accident

Start date: 2001-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.